Clinical Trials Browser

Phase 2 × Neoplasms × tasquinimod × Clear all

NCT00560482 2015-10-26

Efficacy Study of ABR-215050 to Treat Prostate Cancer

Phase 2 Completed

Neoplasms, Prostatic Neoplasms